Tickers

1. Composite Trajectory Verdict

Given ARRY's project-based manufacturing model with significant working capital swings and recurring impairment charges, the income statement and cash flow statement carry roughly equal weight for assessing trajectory, while the balance sheet reflects the cumulative effect of both.

Composite Trajectory: Mixed

Annual results show clear improvement from 2024 to 2025: revenue rose 40% to $1.284B, the operating loss narrowed from -$227.0M to -$29.0M, and the net loss narrowed from -$240.4M to -$52.2M (10-K 2025-12-31, Consolidated Statements of Operations). However, quarterly trends in 2026 reverse this momentum: six-month revenue fell 15% to $565.5M, operating income dropped 43% to $41.9M, and net income fell 56% to $26.3M versus the prior-year period (10-Q 2026-06-30, Consolidated Statements of Operations). Cash flow mirrors this split: annual operating cash flow has declined three consecutive years ($232.0M → $154.0M → $101.8M), yet six-month operating cash flow surged to $91.9M from $30.8M (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Statements of Cash Flows). The balance sheet shows cash rebuilding ($244.4M → $307.3M) and a modest equity deficit improvement (-$206.3M → -$202.1M), but the Series A preferred liquidation preference continues accreting ($466.7M → $498.2M) and total liabilities exceed assets (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets).

2. Red Flags

• Gross margin collapse despite revenue growth: Consolidated gross margin fell from 32.5% (2024) to 23.2% (2025) while revenue grew 40%, driven by a 22% CPW increase in Array Legacy Operations (13% tariffs, 6% reduced 45X benefit, 3% inflation) and a $29.5M inventory valuation charge in STI Operations (10-K 2025-12-31, Consolidated Statements of Operations and MD&A).
• Recurring goodwill impairments: STI Operations goodwill impaired $236.0M in 2024 and $102.6M in 2025, eliminating the segment's entire goodwill balance (10-K 2025-12-31, Consolidated Statements of Operations and Note 7).
• Persistent negative equity: Stockholders' equity remained deeply negative at -$118.1M (2024), -$206.3M (2025), and -$202.1M (Q2 2026) (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets).
• Series A preferred accretion accelerating: Liquidation preference grew from $406.9M (2024) to $466.7M (2025) to $498.2M (Q2 2026); after August 10, 2026, dividends become cash-only at Cash Regular Dividend Rate + 200bps (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets and Series A Redeemable Perpetual Preferred Stock note).
• Three-year decline in annual operating cash flow: $232.0M (2023) → $154.0M (2024) → $101.8M (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Revenue contraction in 2026: Six-month revenue down 15% YoY, driven by an 83% decline in STI Operations volume (10-Q 2026-06-30, Consolidated Statements of Operations and MD&A).
• Inventory valuation charge: $29.5M one-time charge in 2025 related to STI Operations phase-out of non-SmarTrack®-compatible H250 product (10-K 2025-12-31, Consolidated Statements of Operations and MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results improved markedly from 2024 to 2025: revenue increased 40% to $1.284B, gross profit was essentially flat at $298.6M (margin compressed from 32.5% to 23.2%), operating loss narrowed from -$227.0M to -$29.0M, and net loss narrowed from -$240.4M to -$52.2M (10-K 2025-12-31, Consolidated Statements of Operations). The improvement was driven by Array Legacy Operations (revenue +62%, gross profit +11%) while STI Operations deteriorated (revenue -16%, gross profit swung from +$27.6M to -$1.4M) (10-K 2025-12-31, MD&A). In contrast, the first half of 2026 shows deterioration versus the first half of 2025: six-month revenue fell 15% to $565.5M, gross profit fell 6% to $162.6M (though margin improved to 28.8% from 26.1%), operating income fell 43% to $41.9M, and net income fell 56% to $26.3M (10-Q 2026-06-30, Consolidated Statements of Operations). STI Operations revenue collapsed 83% and generated a gross loss of $1.1M, while Array Legacy Operations grew revenue 6% and gross profit 9% (10-Q 2026-06-30, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow has declined for three consecutive years: $232.0M (2023) → $154.0M (2024) → $101.8M (2025), reflecting lower earnings and working capital outflows (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, the six-month comparison shows a sharp reversal: operating cash flow jumped to $91.9M in H1 2026 from $30.8M in H1 2025, driven by $26.3M net income, $47.5M non-cash adjustments, and an $18.0M favorable working capital change versus a $54.3M outflow in the prior year (10-Q 2026-06-30, Consolidated Statements of Cash Flows and MD&A). Investing cash outflows spiked to $187.9M in 2025 due to the $164.9M APA acquisition, versus $9.6M in 2024; H1 2026 investing outflows were $15.1M (primarily capex) versus $9.0M in H1 2025 (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Statements of Cash Flows). Financing activities in 2025 included $334.6M convertible note proceeds, $233.9M term loan repayment, $78.4M 2028 note repurchase, and $35.1M capped call premium; H1 2026 financing used $17.1M net, mainly $51.0M other debt repayment offset by $38.3M new other debt proceeds (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Cash and equivalents rose from $244.4M (Dec 2025) to $307.3M (Jun 2026), with $32.3M and $25.8M held outside the U.S. respectively (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets). Total assets grew from $1.452B to $1.534B, driven by higher receivables ($271.6M → $323.4M), lower prepaid/other current assets ($201.1M → $104.6M), and higher other non-current assets ($29.7M → $109.2M) (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets). Total liabilities increased from $1.191B to $1.238B; the revolving credit facility was expanded from $166M to $370M (maturity extended to Feb 2031), with $332.9M available at Jun 2026 (10-Q 2026-06-30, MD&A and Consolidated Balance Sheets). Long-term debt net of current portion was essentially flat at ~$658M. Series A Redeemable Perpetual Preferred Stock carrying value grew from $466.7M to $498.2M (liquidation preference $493.1M → $506.4M) (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets). Stockholders' deficit improved slightly from -$206.3M to -$202.1M, but remains negative (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets). Goodwill stands at $135.2M (all Array Legacy Operations; STI Operations goodwill fully impaired) (10-K 2025-12-31 and 10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

• Stand-alone Q1 2026 and Q3 2025 income statement, cash flow, and balance sheet figures (only YTD and Q2 2026, plus annual 2025/2024/2023, are provided)
• Quarterly segment gross margin and volume/ASP trends for Q1 2026 and Q3/Q4 2025
• Detailed working capital component changes for annual 2025 (only net change disclosed)
• Full-year 2026 guidance or updated long-term projections post-OBBB
• Resolution of APA purchase price adjustments (measurement period ends August 2026)
• Outcome of AD/CVD investigations on India/Indonesia/Laos and Section 232 polysilicon investigation
• Supreme Court IEEPA tariff refund process and potential cash impact
• AWM acquisition closing status and purchase price allocation (expected Q3 2026)